Jump to content

Lytico-bodig disease

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Jnestorius (talk | contribs) at 00:47, 14 June 2020 (→top: | synonyms = Guam disease, amyotrophic lateral sclerosis-parkinsonism-dementia, ALS-PDC). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Lytico-bodig disease
Other namesGuam disease, amyotrophic lateral sclerosis-parkinsonism-dementia, ALS-PDC

Lytico-bodig (also Lytigo-bodig[1]) disease, Guam disease, or amyotrophic lateral sclerosis-parkinsonism-dementia (ALS-PDC)[2] is a neurodegenerative disease of uncertain etiology endemic to the Chamorro people of the island of Guam in Micronesia. Lytigo and bodig are Chamorro language words for two different manifestations of the same condition. ALS-PDC, a term coined by Asao Hirano and colleagues in 1961, reflects its resemblance to amyotrophic lateral sclerosis (ALS), Parkinson's disease, and Alzheimer's disease.[3]

First reports of the disease surfaced in three death certificates on Guam in 1904 which made some mention of paralysis. The frequency of cases grew amongst the Chamorro until it was the leading cause of adult death between 1945 and 1956.[4] The incidence rate was 200 per 100,000 per year and it was 100 times more prevalent than in the rest of the world.[2][5] Neurologist Oliver Sacks detailed this disease in his book The Island of the Colorblind.[6] Sacks and Paul Alan Cox subsequently wrote that the Guam flying fox, a bat extinct due to overhunting, had been feeding on Federico nuts (Cycas micronesica) and concentrating β-methylamino-L-alanine (BMAA), a known neurotoxin, in its body fat.[7] The hypothesis suggests that consumption of the bat by the Chamorro exposed them to BMAA, contributing to or causing their condition.[8][9] Decline in consumption of the bats has been linked to a decline in the incidence of the disease.[10]

Symptoms

Lytico-bodig disease presents itself in two ways:

Lytico

As with bodig, the symptoms and forms of lytico present themselves differently from patient to patient.

Patient presentations include muscle atrophy, maxillofacial paralysis, inability to speak or swallow and subsequent choking. Some patients retain mental lucidity throughout the illness until death, much like ALS patients.

Diaphragm and respiratory accessory muscles can become paralyzed necessitating mechanical ventilation to facilitate breathing. Saliva must be suctioned from the mouth to prevent aspiration. This form of lytico-bodig is fatal in all cases.

Bodig

No standard form of bodig has been reported and the documented cases of the disease manifested in many different clinical presentations.

The doctor visited a patient who had just suddenly come down with a virulent form. His symptoms had begun 18 months before, starting with a strange immobility and a loss of initiative and spontaneity; he found he had to make a huge effort to walk, to stand, and to make the least movement—his body was disobedient. The immobility attacked with frightening speed, and within a year, he was unable to stand alone and could not control his posture (2006).

—Oliver Sacks, The Island of the Colorblind, Vintage Books, 1996

Progressive dementia is also characteristic of bodig. Those who experience dementia are often aphasic and restless, and demonstrate irrational behavior, such as violence, and deep emotions at odd intervals. Patients experience manic highs and lows, giggling one minute and screaming the next.

Patients in the most virulent stage present with mouths hanging open, with excessive salivation; their tongues hang motionless, rendering speech and swallowing impossible. The patient’s arms and legs become severely spastic and bent in immovable tension.

The advanced progression presents as profound motionlessness, or catatonia, accompanied with tremors or rigidity. Except in cases with concurrent dementia, most patients are capable of lucid thought and speech throughout the disease’s physical progression.

Cause

Some hypotheses as to the cause of the disease include genetics, cycad seeds, and ingested beta-Methylamino-L-alanine (BMAA) from the consumption of fruit bats.

Genetic hypothesis

Genetics was first hypothesized due to the situation on Guam. Lytico-bodig was found in great numbers among members of the Chamorro community, so genetic factors were possible. The disease was shown to be familial but not genetic. Chamorro who grew up outside of Guam had not developed the disease, and some non-Chamorro who moved to the island and followed the culture did develop it.[11]

Cycad hypothesis

The starch from the indigenous Cycas micronesica seeds are consumed in the traditional Chamorro diet. The seeds are ground to make a flour called fadang, and the flour is then used to make flatbread and dumplings. The flour is soaked and washed several times as the seed in its natural form is extremely toxic. Ample research on the cycad hypothesis found a component of the seeds, cycasin, was a potent toxin; it was discovered in the 1950s. As toxic as it was, it would not be the cause of the symptoms of lytico-bodig. Not only that, after nearly two decades of NIH-funded researches, animal models failed to reproduce the chronic Lytico-Bodig and the hypothesis was rejected for the first time.[5]

In 1967, following studies that linked lathyrism to ODAP, Marjorie Whiting, a nutritional antrophologist asked Arthur Bell, a plant biochemist, to test cycad seeds.[12] Arthur Bell and his colleagues discovered another toxic substance in the seeds, BMAA (beta-Methylamino-L-alanine).[13] Initial laboratory results found low levels of free BMAA in cycad flour.[14][15] The cycad hypothesis was abandoned the second time because the acute toxicity showed by Spencer and Nunn was due to BMAA concentrations in orders of magnitude higher.[5] Further laboratory analysis which included protein-bound BMAA found significant levels in fadang, and found also that the levels were higher in fadang made at settlements with a higher incidence of lytico-bodig.[16]

The theory was resurrected by Paul Alan Cox and Oliver Sacks after re-examining aspects of the Chamorro diet.[7] Cox and his colleagues found that BMAA is produced by symbiotic cyanobacteria found in the coralloid roots of cycads.[5] Other than that, fruit bats or flying foxes, feeds on cycad seeds, and were a common food for the Chamorros. The bats bioaccumulate BMAA in their fat, and eating even a few bats would cause a dose of BMAA similar to levels that produced disease symptoms in the earlier animal models. The content of free BMAA in fruit bats was up to 3 mg/g (approximately 30 mM), while that in the broth in which the fruit bats had been cooked was up to 3 mg/250 ml.[17] Cox also observed decline in fruit bat consumption matching the decline in lytico-bodig.[10][18] Support for the BMAA theory of the Guam disease came from the finding reported in 2016 that chronic dietary exposure of vervet monkeys homozygous for the APOE4 gene (which in humans increases risk of Alzheimer's disease) to the cyanobacterial toxin BMAA produces dense neurofibrillary tangles and sparse amyloid plaques similar to that found in the brains of Chamorro villagers in Guam who died from lytico-bodig.[19]

Mechanism

The mechanism is complex and poorly understood. During autopsies, neurofibrillary tangles are found in the brain which are congruent to the brain of an Alzheimer's patient.

The following is an excerpt from Island of the Colorblind, in which samples of substantia nigra are viewed under microscope. "Many of the cells are pale and depigmented. There's a lot of glial reaction, and bits of loose pigment. Shifting to a higher power, he saw a huge number of neurofibrillary tangles, densely staining, convoluted masses, harshly evident within the destroyed nerve cells."[6] Looking at other samples of hypothalamus, spinal cord, and cortex, all were full of neurofibrillary tangles. Neurofibrillary degeneration was everywhere. These slides were similar in appearance to those taken from postencephalitic parkinsonism.

While neurofibrillary degeneration is a potential cause of lytico-bodig, much is still undiscovered as to what causes the symptoms, what governs the severity, and how the onset of symptoms progresses. Similar symptoms of Postencephalitic Parkinsonism patients and Alzheimer's patients could account for the similarities in symptoms of lytico and bodig. Lytico-bodig, postencephalitis, and Alzheimer's could possibly be the same disease taking three different forms.

Age of onset seems to be increasing with no more teenage cases and almost no patients in their twenties. Presentation also varies between years. One form of the disease will present itself chiefly in one decade and then another form predominates in the next.

No treatment has been found to cure lytico-bodig. In some cases, the drug L-DOPA was given to patients to alleviate some of the symptoms of bodig, but this only gave the patients one or two hours of freedom from the complete paralysis and rigidity of limbs. It seems in the case of the Chamorros, family members are the primary caregivers, and they have accepted those who are ill and provide home care for all those inflicted with lytico-bodig.

See also

References

  1. ^ Golbe LI (September 2000). "Progressive supranuclear palsy in the molecular age". Lancet. 356 (9233): 870–1. doi:10.1016/S0140-6736(00)02672-6. PMID 11036887.
  2. ^ a b Steele JC (August 2005). "Parkinsonism-dementia complex of Guam". Mov. Disord. 20 Suppl 12: S99–S107. doi:10.1002/mds.20547. PMID 16092098.
  3. ^ Moisse, Katie (2013-09-24). ""A Batty Hypothesis on the Origins of Neurodegenerative Disease Resurfaces," Scientific American". Scientificamerican.com. Retrieved 2013-09-28.
  4. ^ Brody JA, Chen K (1969). "Changing epidemiologic patterns of Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia on Guam". Motor neuron diseases research on ALS and related disorders: 61–79.
  5. ^ a b c d Bradley WG, Mash DC (2009). "Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases". Amyotroph Lateral Scler. 10 Suppl 2: 7–20. doi:10.3109/17482960903286009. PMID 19929726.
  6. ^ a b Sacks, Oliver (2006). The Island of the Colorblind. New York: Random House. ISBN 0-679-77545-5.
  7. ^ a b Cox PA, Banack SA, Murch SJ (November 2003). "Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam". Proc. Natl. Acad. Sci. U.S.A. 100 (23): 13380–3. doi:10.1073/pnas.2235808100. PMC 263822. PMID 14612559.
  8. ^ Holtcamp W (March 2012). "The emerging science of BMAA: do cyanobacteria contribute to neurodegenerative disease?". Environ. Health Perspect. 120 (3): A110–6. doi:10.1289/ehp.120-a110. PMC 3295368. PMID 22382274.
  9. ^ Miller G (July 2006). "Neurodegenerative disease. Guam's deadly stalker: on the loose worldwide?". Science. 313 (5786): 428–31. doi:10.1126/science.313.5786.428. PMID 16873621.
  10. ^ a b Monson CS, Banack SA, Cox PA (2003). "Conservation implications of Chamorro consumption of flying foxes as a possible cause of amyotrophic lateral sclerosis-parkinsonism dementia complex in Guam". Conservation Biology. 17 (3): 678–686. doi:10.1046/j.1523-1739.2003.02049.x.
  11. ^ Morris HR, Al-Sarraj S, Schwab C, Gwinn-Hardy K, Perez-Tur J, Wood NW, Hardy J, Lees AJ, McGeer PL, Daniel SE, Steele JC (November 2001). "A clinical and pathological study of motor neurone disease on Guam". Brain. 124 (Pt 11): 2215–22. doi:10.1093/brain/124.11.2215. PMID 11673323.
  12. ^ Holtcamp W (March 2012). "The emerging science of BMAA: do cyanobacteria contribute to neurodegenerative disease?". Environ. Health Perspect. 120 (3): A110–6. doi:10.1289/ehp.120-a110. PMC 3295368. PMID 22382274.
  13. ^ Vega A, Bell EA (1967). "Alpha-amino-beta-methylaminopropionic acid, a new amino acid from seeds of cycas circinalis". Phytochemistry. 16: 759–762. doi:10.1016/s0031-9422(00)86018-5.
  14. ^ Duncan MW, Steele JC, Kopin IJ, Markey SP (May 1990). "2-Amino-3-(methylamino)-propanoic acid (BMAA) in cycad flour: an unlikely cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam". Neurology. 40 (5): 767–72. doi:10.1212/wnl.40.5.767. PMID 2330104.
  15. ^ Kisby GE, Ellison M, Spencer PS (July 1992). "Content of the neurotoxins cycasin (methylazoxymethanol beta-D-glucoside) and BMAA (beta-N-methylamino-L-alanine) in cycad flour prepared by Guam Chamorros". Neurology. 42 (7): 1336–40. doi:10.1212/wnl.42.7.1336. PMID 1620343.
  16. ^ Cheng R, Banack SA (2009). "Previous studies underestimate BMAA concentrations in cycad flour". Amyotroph Lateral Scler. 10 Suppl 2: 41–3. doi:10.3109/17482960903273528. PMID 19929730.
  17. ^ Banack SA, Murch SJ, Cox PA (June 2006). "Neurotoxic flying foxes as dietary items for the Chamorro people, Marianas Islands". J Ethnopharmacol. 106 (1): 97–104. doi:10.1016/j.jep.2005.12.032. PMID 16457975.
  18. ^ Banack SA, Cox PA (2003). "Biomagnification of cycad neurotoxins in flying foxes". Neurology. 61: 387–389. doi:10.1212/01.wnl.0000078320.18564.9f. PMID 12913204.
  19. ^ Cox PA, Davis DA, Mash DC, Metcalf JS, Banack SA (January 2016). "Dietary exposure to an environmental toxin triggers neurofibrillary tangles and amyloid deposits in the brain". Proc. Biol. Sci. 283 (1823). doi:10.1098/rspb.2015.2397. PMC 4795023. PMID 26791617.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Lytico-bodig_disease&oldid=962428895"